North America Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Country and Growth Forecast, 2023 - 2030

The North America Arthritic Therapeutic Market would witness market growth of 4.5% CAGR during the forecast period (2023-2030).

The US market dominated the North America Arthritic Therapeutic Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $31,321.7 Million by 2030. The Canada market is experiencing a CAGR of 6.8% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.9% during (2023 - 2030).

Adopting arthritic therapeutics hinges on the availability of safe and efficacious treatments that effectively alleviate symptoms, preserve joint function, and enhance overall quality of life. Clinical trials and real-world evidence demonstrating the benefits of various pharmacological and non-pharmacological interventions are crucial in informing treatment decisions and shaping clinical practice guidelines.

The adoption of this is influenced by the availability and accessibility of healthcare infrastructure, like rheumatology clinics, primary care providers, physical therapy facilities, and diagnostic services. Adequate healthcare resources, including trained personnel, medical equipment, and pharmaceutical supplies, are essential for delivering comprehensive arthritis care and implementing evidence-based treatment protocols.

According to the Canadian Institute for Health Information, Canada’s senior population of those 65 and older will expand by 68% over the next 20 years. It has more than tripled in size in the last 40 years. In 2017, it was around 6.2 million. It is anticipated to reach 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017. Arthritis is one of the most common chronic conditions among older adults in Canada. Hence, the factors mentioned above will drive the regional market growth.

Free Valuable Insights: The Arthritic Therapeutic Market is Predict to reach USD 112.6 Billion by 2030, at a CAGR of 5.1%

Based on Application, the market is segmented into Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others. Based on Product Type, the market is segmented into Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modified Anti-rheumatoid Drugs (DMARDs), Biologics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• AbbVie, Inc.
• Pfizer, Inc.
• Amgen, Inc.
• Novartis AG
• F.Hoffmann-La Roche Ltd.
• Viatris, Inc.
• Bausch Health Companies, Inc.
• Sanofi S.A.
• Merck & Co., Inc.
• Bristol-Myers Squibb Company

North America Arthritic Therapeutic Market Report Segmentation

By Application

• Rheumatoid Arthritis
• Psoriatic Arthritis
• Osteoarthritis
• Ankylosing Spondylitis
• Others

By Product Type

• Non-steroidal Anti-inflammatory Drugs (NSAIDs)
• Disease Modified Anti-rheumatoid Drugs (DMARDs)
• Biologics
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Arthritic Therapeutic Market, by Application
1.4.2 North America Arthritic Therapeutic Market, by Product Type
1.4.3 North America Arthritic Therapeutic Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Recent Strategies Deployed in the Arthritic Therapeutic Market

Chapter 5. North America Arthritic Therapeutic Market, by Application
5.1 North America Rheumatoid Arthritis Market, by Country
5.2 North America Psoriatic Arthritis Market, by Country
5.3 North America Osteoarthritis Market, by Country
5.4 North America Ankylosing Spondylitis Market, by Country
5.5 North America Others Market, by Country

Chapter 6. North America Arthritic Therapeutic Market, by Product Type
6.1 North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country
6.2 North America Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country
6.3 North America Biologics Market, by Country
6.4 North America Others Market, by Country

Chapter 7. North America Arthritic Therapeutic Market, by Country
7.1 US Arthritic Therapeutic Market
7.1.1 US Arthritic Therapeutic Market, by Application
7.1.2 US Arthritic Therapeutic Market, by Product Type
7.2 Canada Arthritic Therapeutic Market
7.2.1 Canada Arthritic Therapeutic Market, by Application
7.2.2 Canada Arthritic Therapeutic Market, by Product Type
7.3 Mexico Arthritic Therapeutic Market
7.3.1 Mexico Arthritic Therapeutic Market, by Application
7.3.2 Mexico Arthritic Therapeutic Market, by Product Type
7.4 Rest of North America Arthritic Therapeutic Market
7.4.1 Rest of North America Arthritic Therapeutic Market, by Application
7.4.2 Rest of North America Arthritic Therapeutic Market, by Product Type

Chapter 8. Company Profiles
8.1 AbbVie, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Amgen, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Novartis AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Trials and Approvals:
8.4.6 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Viatris, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Trials and Approvals:
8.6.6 SWOT Analysis
8.7 Bausch Health Companies, Inc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 Merck & Co., Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. Bristol-Myers Squibb Company
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis

TABLE 1 North America Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 2 North America Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 3 North America Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 4 North America Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 5 North America Rheumatoid Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 6 North America Rheumatoid Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 7 North America Psoriatic Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 8 North America Psoriatic Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 9 North America Osteoarthritis Market, by Country, 2019 - 2022, USD Million
TABLE 10 North America Osteoarthritis Market, by Country, 2023 - 2030, USD Million
TABLE 11 North America Ankylosing Spondylitis Market, by Country, 2019 - 2022, USD Million
TABLE 12 North America Ankylosing Spondylitis Market, by Country, 2023 - 2030, USD Million
TABLE 13 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 14 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 15 North America Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 16 North America Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 17 North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2019 - 2022, USD Million
TABLE 18 North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2023 - 2030, USD Million
TABLE 19 North America Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2019 - 2022, USD Million
TABLE 20 North America Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2023 - 2030, USD Million
TABLE 21 North America Biologics Market, by Country, 2019 - 2022, USD Million
TABLE 22 North America Biologics Market, by Country, 2023 - 2030, USD Million
TABLE 23 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 24 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 25 North America Arthritic Therapeutic Market, by Country, 2019 - 2022, USD Million
TABLE 26 North America Arthritic Therapeutic Market, by Country, 2023 - 2030, USD Million
TABLE 27 US Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 28 US Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 29 US Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 30 US Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 31 US Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 32 US Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 33 Canada Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 34 Canada Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 35 Canada Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 36 Canada Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 37 Canada Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 38 Canada Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 39 Mexico Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 40 Mexico Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 41 Mexico Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 42 Mexico Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 43 Mexico Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 44 Mexico Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 45 Rest of North America Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 46 Rest of North America Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 47 Rest of North America Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 48 Rest of North America Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 49 Rest of North America Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 50 Rest of North America Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 51 Key information – AbbVie, Inc.
TABLE 52 Key Information – Pfizer, Inc.
TABLE 53 Key Information – Amgen, Inc.
TABLE 54 Key Information – Novartis AG
TABLE 55 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 56 Key Information – Viatris, Inc.
TABLE 57 key information – Bausch Health Companies, Inc.
TABLE 58 Key Information – Sanofi S.A.
TABLE 59 Key Information - Merck & Co., Inc.
TABLE 60 Key Information – Bristol-Myers Squibb Company

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Arthritic Therapeutic Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Arthritic Therapeutic Market
FIG 4 Porter’s Five Forces Analysis - Arthritic Therapeutic Market
FIG 5 North America Arthritic Therapeutic Market share, by Application, 2022
FIG 6 North America Arthritic Therapeutic Market share, by Application, 2030
FIG 7 North America Arthritic Therapeutic Market, by Application, 2019 - 2030, USD Million
FIG 8 North America Arthritic Therapeutic Market share, by Product Type, 2022
FIG 9 North America Arthritic Therapeutic Market share, by Product Type, 2030
FIG 10 North America Arthritic Therapeutic Market, by Product Type, 2019 - 2030, USD Million
FIG 11 North America Arthritic Therapeutic Market share, by Country, 2022
FIG 12 North America Arthritic Therapeutic Market share, by Country, 2030
FIG 13 North America Arthritic Therapeutic Market, by Country, 2019 - 2030, USD Million
FIG 14 Swot Analysis: AbbVie, Inc.
FIG 15 SWOT Analysis: Pfizer, Inc.
FIG 16 Swot Analysis: Amgen, Inc.
FIG 17 SWOT Analysis: Novartis AG
FIG 18 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 19 SWOT Analysis: Viatris, Inc.
FIG 20 SWOT Analysis: Bausch Health Companies, Inc.
FIG 21 Swot Analysis: Sanofi S.A.
FIG 22 SWOT Analysis: Merck & Co., Inc.
FIG 23 SWOT Analysis: Bristol-Myers Squibb Company